This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

NSH education webinar: Tips for Using Student Evaluations to Assess Teaching Effectiveness
1-2 p.m. EDT, June 3
Presented by Debra Wood, M.S.Ed., HT(ASCP), Indiana University School of Medicine, Indianapolis

The purpose of this webinar is to provide instructors with information concerning the utility and biases associated with Student Evaluations of Teaching (SETs). Use SET Ratings to estimate overall teaching effectiveness and to provide general feedback so that instructors can use results to make positive changes in their teaching practice. We will also look at potential biases, as well as validity and reliability of the instruments themselves, so that the instruments can be improved over time. To register, click here.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




NSH open registration for IHC Forum
This all-day forum, developed by Dr. Richard Cartun in conjunction with the NSH IHC Committee, features advanced topics in the field of clinical immunohistochemistry and molecular diagnostics. The course is designed to maximize attendee networking through General Sessions and access to expert instructors throughout the day during Q&A sessions following each topic. Click here for more information.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


NSH open registration for HT/HTL study weekend
Studying for the ASCP Board of Certification Exam is a huge undertaking. That difficulty is increased even more when you are doing it on your own. The amount of time and discipline it takes can be overwhelming. For the first time NSH is offering not only an HT Prep but also an HTL Prep. Attendees can choose one day or stay for the entire weekend. This one of a kind study weekend will be presented by Sarah Britton, BS, HTL(ASCP)cm, program director at William Beaumont Hospital in Royal Oak, Missouri, and is designed to help guide you through the certification process. Learn more.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


TOP STORIES


Building better clinical trials in China
Forbes
Yangfeng Wu is the executive associate director at Peking University Clinical Research Institute, an academic center based in Beijing that collaborates with government organizations and companies to raise the level of clinical research in China. Wu was trained as a cardiologist and epidemiologist and has been involved in clinical trials with international partners for the past 30 years. We spoke with Wu about the current landscape for clinical trials in China and where he sees the country's clinical trial industry heading in the next 10 years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


US science leaders to tackle ethics of gene-editing technology
Reuters
The leading United States scientific organization, responding to concerns expressed by scientists and ethicists, has launched an ambitious initiative to recommend guidelines for new genetic technology that has the potential to create "designer babies." The technology, called CRISPR-Cas9, allows scientists to edit virtually any gene they target. The technique is akin to a biological word-processing program that finds and replaces genetic defects.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




The new paradigm of healthcare delivery
ADVANCE for Laboratory Administrators
As a nation, our healthcare system is transitioning to a service mode, where there is more emphasis on value. The economic task for medical laboratories of the future is to think about how they can diagnose patients efficiently, providing the maximum benefit for the lowest cost.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


Researchers taking bold steps toward engineering new lungs
Arizona State University via Medical Xpress
According to the World Health Organization, chronic obstructive pulmonary disease currently affects more than 64 million people worldwide and is poised to become the third leading cause of mortality by 2030. A hallmark of COPD is scarring of the lungs, a condition called pulmonary fibrosis, which impacts breathing. There is no cure for the condition or ability to repair the scarring that has occurred. Thus, in the late stages of lung disease, one remedy exists: organ transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
 


Has the time come for integration of radiology and pathology?
Dark Daily
For years, certain pathologists and radiologists have floated the idea that an integrated diagnostic service involving both medical specialties could improve patient safety and contribute to improved patient outcomes. Now that the United States healthcare system is encouraging tighter integration of clinical services, advocates of an integrated diagnostic service involving radiology and pathology believe that the era of integrated diagnostics may be soon upon us.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


IN THE NEWS


Precision medicine is 'personalized, problematic and promising'
University of Pennsylvania School of Medicine via Medical Xpress
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, M.D., Ph.D., dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System. Precision medicine raises the potential of a "daunting explosion of information and the associated clinical guidelines." Moreover it creates a set of conditions where the interests of patients, physicians, health systems, insurance companies, government agencies, and the pharmaceutical industry may not fully coincide, setting the stage for an absence of consensus on appropriate care choices.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




The promise of the digital health revolution for clinical trials
Forbes
The global head of research at Sanofi put a policy in place to attach a digital health strategy concept to each molecule that goes through the pharmaceutical company's pipeline. The fact that a digital strategy is reaching into the depths of the largest pharma companies is extremely encouraging for the continued evolution of clinical development, says Donald Jones, the chief digital officer at Scripps Translational Science Institute, which serves as the world's first clinical trials center focused exclusively on digital medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Trialbee raises $5 million to bring mobile-enabled clinical trials business
to US

MobiHealthNews
Swedish clinical trial recruitment company Trialbee has raised $5 million in first-round funding from existing investors Industrifonden and Briban Invest. The company previously raised about $3.2 million in seed funding. The money will be used, among other things, to support Trialbee's entrance into the United States market.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


More hospitals closed due to empty beds as providers succeed in reducing hospital admissions; pathologists should respond with outpatient/outreach services
Dark Daily
Declining patient volume is shuttering hospitals across the United States as hospitals lose patients to ambulatory care centers and home-based medical care. This trend directly impacts the pathologists and medical technologists who work in the clinical laboratories of these hospitals. Most pathologists are unaware that, between 2008 and 2013, nearly 130 community hospitals closed. That left 4,974 hospitals operating in the U.S., according to American Hospital Association 2015 Hospital Statistics, which are based on data from the 2013 AHA Annual Survey.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Medical lab inspections questioned
Record Searchlight
Kristin Turner had warned her boss several times that the blood analyzer at Maryland General Hospital wasn't working properly. It would break down in the middle of testing; samples were cross-contaminated; lab technicians couldn't validate the machine to be confident it generated correct results. The machine was never fixed. On March 12, 2003, Turner used the analyzer to run tests for HIV and hepatitis C. There were about 88 patient samples on the analyzer that day, she remembers. Many of the samples were being analyzed to confirm a previous positive HIV test.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Profit and greed at an embattled laboratory company (Forbes)
Pathologists watching phase II of a clinical trial for breathalyzer system that uses only breath specimen to diagnose lung cancer (Dark Daily)
Scientists are able to take immortality from cancer (Centro Nacional de Investigaciones Oncologicas via Medical Xpress)
UnitedHealthcare pilot to curb lab costs draws protest (Modern Healthcare)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
May 20, 2015
May 19, 2015 Blast
May 13, 2015
May 6, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063